Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Five modifiable risk factors are associated with cardiovascular disease and death from any cause. Studies using individual-level data to evaluate the regional and sex-specific prevalence of the risk factors and their effect on these outcomes are lacking. METHODS: We pooled and harmonized individual-level data from 112 cohort studies conducted in 34 countries and 8 geographic regions participating in the Global Cardiovascular Risk Consortium. We examined associations between the risk factors (body-mass index, systolic blood pressure, non-high-density lipoprotein cholesterol, current smoking, and diabetes) and incident cardiovascular disease and death from any cause using Cox regression analyses, stratified according to geographic region, age, and sex. Population-attributable fractions were estimated for the 10-year incidence of cardiovascular disease and 10-year all-cause mortality. RESULTS: Among 1,518,028 participants (54.1% of whom were women) with a median age of 54.4 years, regional variations in the prevalence of the five modifiable risk factors were noted. Incident cardiovascular disease occurred in 80,596 participants during a median follow-up of 7.3 years (maximum, 47.3), and 177,369 participants died during a median follow-up of 8.7 years (maximum, 47.6). For all five risk factors combined, the aggregate global population-attributable fraction of the 10-year incidence of cardiovascular disease was 57.2% (95% confidence interval [CI], 52.4 to 62.1) among women and 52.6% (95% CI, 49.0 to 56.1) among men, and the corresponding values for 10-year all-cause mortality were 22.2% (95% CI, 16.8 to 27.5) and 19.1% (95% CI, 14.6 to 23.6). CONCLUSIONS: Harmonized individual-level data from a global cohort showed that 57.2% and 52.6% of cases of incident cardiovascular disease among women and men, respectively, and 22.2% and 19.1% of deaths from any cause among women and men, respectively, may be attributable to five modifiable risk factors. (Funded by the German Center for Cardiovascular Research (DZHK); ClinicalTrials.gov number, NCT05466825.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“As well as the significant improvement in diabetic control, cardiometabolic risk was also improved by a significant reduction in SBP which was recorded across the cohort, specifically for those who had one or more co-existing medical conditions and for those who had a diagnosis of T2D of less than 6 years29.”
From mHealth low carbohydrate dietary intervention ameliorates glycaemic profile, blood pressure and weight status in people with type 2 diabetes (2025) · cites this paper as [29]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mice: Multivariate Imputation by Chained Equations in R
Buuren, S. V., & Groothuis-Oudshoorn, K. (2011) · Journal of Statistical Software · doi:10.18637/jss.v045.i03 · Cited by 13,870
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
Roth, G. A., Mensah, G. A., Johnson, C. O., Addolorato, G., Ammirati, E., Baddour, L. M., Barengo, N. C., Beaton, A. Z., Benjamin, E. J., Benziger, C. P., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.010 · Cited by 11,449
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
The SPRINT Research Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1511939 · Cited by 6,325
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Sabatine, M. S., Giugliano, R. P., Keech, A. C., Honarpour, N., Wiviott, S. D., Murphy, S. A., Kuder, J. F., Wang, H., Liu, T., Wasserman, S. M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1615664 · Cited by 6,138 · cited 1×
“Although very low non-HDL cholesterol concentrations are related to reduced CVD events, 25,26 some observations point towards higher all-cause mortality rates in individuals with very low levels at least in longer-term follow-up.”
(2010) · University of Twente Research Information · Cited by 6,037
Auditory and non-auditory effects of noise on health
Basner, M., Babisch, W., Davis, A., Brink, M., Clark, C., Janssen, S., & Stansfeld, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61613-x · Cited by 2,473 · cited 1×
“Environmental and exposomal factors such as physical activity 18 , alcohol consumption 28 , air pollution 29 , climate and noise 30 , educational level 3 or psychosocial risk factors including depression 31 impact CVD risk.”
Global burden of blood-pressure-related disease, 2001
Lawes, C. M., Hoorn, S. V., & Rodgers, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60655-8 · Cited by 2,330 · cited 3×
“While tobacco consumption is strongly associated with premature mortality, elevated blood pressure and cholesterol are more specifically related to CVD. 7 A tailored reduction in the burden of CVD and all-cause mortality for persons and populations can be achieved with better understanding of the region-and sex-specif…”
InfluentialEfficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
Robinson, J. G., Farnier, M., Krempf, M., Bergeron, J., Luc, G., Averna, M., Stroes, E. S., Langslet, G., Raal, F. J., El Shahawy, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501031 · Cited by 2,296 · cited 1×
“Although very low non-HDL cholesterol concentrations are related to reduced CVD events, 25,26 some observations point towards higher all-cause mortality rates in individuals with very low levels at least in longer-term follow-up.”
The Global Burden of Cardiovascular Diseases and Risk
Vaduganathan, M., Mensah, G. A., Turco, J. V., Fuster, V., & Roth, G. A. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.11.005 · Cited by 2,217
Research works printed but not linked: 1
- 18. Yusuf S, Hawken S, Ounpuu S, Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet (London, England) 2004; 364(9438): 937– 52. (In eng). DOI: 10.1016/s0140-6736(04)17018-9. 15364185 · DOI · Paper page
Cited by
European Society of Cardiology: the 2023 Atlas of Cardiovascular Disease Statistics
Timmis, A., Aboyans, V., Vardas, P., Townsend, N., Torbica, A., Kavousi, M., Boriani, G., Huculeci, R., Kazakiewicz, D., Scherr, D., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae466 · Cited by 314
Liu, J., Li, Y., Ge, J., Yan, X., Zhang, H., Zheng, X., Lu, J., Li, X., Gao, Y., Lei, L., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01028-6 · Cited by 258
Cui, C., Liu, L., Qi, Y., Han, N., Xu, H., Wang, Z., Shang, X., Han, T., Zha, Y., Wei, X., et al. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02244-9 · Cited by 186
Global Effect of Cardiovascular Risk Factors on Lifetime Estimates
The Global Cardiovascular Risk Consortium (2025) · New England Journal of Medicine · doi:10.1056/nejmoa2415879 · Cited by 187
Self-citationLinz, D., Andrade, J. G., Arbelo, E., Boriani, G., BREITHARDT, G. E., Camm, A. J., Caso, V., Nielsen, J. C., Melis, M. D., Potter, T. J. R. D., et al. (2024) · EP Europace · doi:10.1093/europace/euae070 · Cited by 129
Saxena, M., Laffin, L. J., Borghi, C., Fernandez, B., Ghali, J. K., Kopjar, B., Polu, K. R., Roger, S. D., Slingsby, B. T., Strutz, F. M., et al. (2025) · JAMA · doi:10.1001/jama.2025.9413 · Cited by 146
Severe mental illness: cardiovascular risk assessment and management
Polcwiartek, C., O’Gallagher, K., Friedman, D. J., Correll, C. U., Solmi, M., Jensen, S. E., & Nielsen, R. E. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae054 · Cited by 117
Diao, J. A., Shi, I., Murthy, V. L., Buckley, T. A., Patel, C. J., Pierson, E., Yeh, R. W., Kazi, D. S., Wadhera, R. K., & Manrai, A. K. (2024) · JAMA · doi:10.1001/jama.2024.12537 · Cited by 116
Heidecker, B., Libby, P., Vassiliou, V. S., Roubille, F., Vardeny, O., Hassager, C., Gatzoulis, M. Α., Mamas, M. A., Cooper, L. T., Schoenrath, F., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf384 · Cited by 110
Choe, H. J., Moon, J. H., Kim, W. K., Koo, B. K., & Cho, N. H. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155800 · Cited by 92
Smoking Cessation and Short- and Longer-Term Mortality
Cho, E. R., Brill, I. K., Gram, I. T., Brown, P. E., & Jha, P. (2024) · NEJM Evidence · doi:10.1056/evidoa2300272 · Cited by 81
Engineered Living Systems Based on Gelatin: Design, Manufacturing, and Applications
Wang, Z., Lin, Z., Mei, X., Cai, L., Lin, K., Rodríguez, J. F., Ye, Z., Parraguez, X. S., Guajardo, E. M., Luna, P. C. G., et al. (2025) · Advanced Materials · doi:10.1002/adma.202416260 · Cited by 97
Cardiovascular Effects of Smoking and Smoking Cessation: A 2024 Update
Rahman, M., Alatiqi, M., Al‐Jarallah, M., Hussain, M. Y., Monayem, A., Panduranga, P., & Rajan, R. (2025) · Global Heart · doi:10.5334/gh.1399 · Cited by 103
Joseph, P., Lanas, F. T., Roth, G., López-Jaramillo, P. A., Lonn, E., Miller, V., Mente, A., Leong, D. P., Schwalm, J.-D., & Yusuf, S. (2025) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2024.100960 · Cited by 138
Obesity accelerates cardiovascular ageing
Ruperez, C., Madeo, F., de Cabo, R., Kroemer, G., & Abdellatif, M. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf216 · Cited by 73
Statin use and dementia risk: A systematic review and updated meta‐analysis
Westphal Filho, F. L., Moss Lopes, P. R., Menegaz de Almeida, A., Sano, V. K. T., Tamashiro, F. M., Gonçalves, O. R., de Moraes, F. C. A., Kreuz, M., Kelly, F. A., & Silveira Feitoza, P. V. (2025) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1002/trc2.70039 · Cited by 62
The Global Syndemic of Modifiable Cardiovascular Risk Factors Projected From 2025 to 2050
Chong, B., Jayabaskaran, J., Jauhari, S. M., Chia, J., le Roux, C. W., Mehta, A., Dimitriadis, G. K., Chen, Y., Toh, S. A., Manla, Y., et al. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.04.061 · Cited by 67
Cardiovascular Statistics in the United States, 2026
Wadhera, R. K., Dhruva, S. S., Bikdeli, B., Bonaca, M. P., Kittleson, M. M., Ko, D. T., Lu, Y., Pagidipati, N. J., Sawano, M., Spatz, E. S., et al. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.12.027 · Cited by 71
An, X., Liu, Z., Zhang, L., Zhao, J., Gu, Q., Han, W., Hu, Y., Fang, X., Zhang, F., Wang, S., et al. (2025) · The Lancet Global Health · doi:10.1016/s2214-109x(25)00013-0 · Cited by 77
Physical Activity and All-Cause Mortality by Age in 4 Multinational Megacohorts
Martínez‐Gómez, D., Luo, M., Huang, Y., Rodríguez‐Artalejo, F., Ekelund, U., Sotos‐Prieto, M., Ding, D., Lao, X. Q., & Cabanas‐Sánchez, V. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.46802 · Cited by 71
Goupil, R., Tsuyuki, R. T., Santesso, N., Terenzi, K. A., Habert, J., Cheng, G., Gysel, S. C., Bruneau, J., Leung, A. A., Campbell, N. R. C., et al. (2025) · Canadian Medical Association Journal · doi:10.1503/cmaj.241770 · Cited by 60
Higher cardiovascular disease risks in people living with HIV: A systematic review and meta-analysis
Zhu, S., Wang, W., He, J., Duan, W., Ma, X., Guan, H., Wu, Y., Li, S., Li, Y., Tian, T., et al. (2024) · Journal of Global Health · doi:10.7189/jogh.14.04078 · Cited by 59
“According to a worldwide study of cardiovascular risk in eight regions [66], the highest prevalence of overweight was found in Latin America, whereas hypertension and high cholesterol were common in Europe.”
The Interplay Between Immunity, Inflammation and Endothelial Dysfunction
Chee, Y. J., Dalan, R., & Cheung, C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041708 · Cited by 70
Rezaieyan, E., Taban, E., Berardi, U., Mortazavi, S. B., Faridan, M., & Mahmoudi, E. (2024) · Journal of Building Engineering · doi:10.1016/j.jobe.2024.108491 · Cited by 57
Krumholz, H. M., de Lemos, J. A., Sattar, N., Linetzky, B., Sharma, P., Mast, C. J., Ahmad, N. N., Bunck, M. C., & Stefanski, A. (2024) · Heart · doi:10.1136/heartjnl-2024-324170 · Cited by 54
Chen, Y., Ji, H., Shen, Y., & Liu, D. (2024) · Archives of Public Health · doi:10.1186/s13690-024-01243-2 · Cited by 57
Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular disease
Agarwal, A., Mehta, P. M., Jacobson, T., Shah, N. S., Ye, J., Zhu, J., Wafford, Q. E., Bahiru, E. M., de Cates, A. N., Ebrahim, S. B. J., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-02896-w · Cited by 56
Dwyer, J. P., Maklad, N. S., Vedin, O., Monyak, J. T., Myte, R., Chertow, G. M., Heerspink, H. J. L., & Little, D. J. (2025) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000849 · Cited by 67
Brunham, L. R., Lonn, E., & Mehta, S. R. (2024) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2024.04.017 · Cited by 60
Epidemiology of cardiometabolic health in Latin America and strategies to address disparities
Brant, L. C. C., Miranda, J. J., Carrillo-Larco, R. M., Flood, D., Irazola, V. E., & Ribeiro, A. L. P. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01058-2 · Cited by 55
Staff, A. C., Costa, M. L., Dechend, R., Jacobsen, D. P., & Sugulle, M. (2024) · Pregnancy Hypertension · doi:10.1016/j.preghy.2024.101127 · Cited by 53
“…global cohort of individual data from > 1.5 million participants, that 53 % of cardiovascular disease and 22 % of deaths in women were attributable to 5 well-known modifiable risk factors (body mass index, systolic blood pressure, non-high-density lipoprotein cholesterol, smoking and diabetes) [3].”
BackgroundInfluentialDietary patterns to promote cardiometabolic health
Pagidipati, N. J., Taub, P. R., Ostfeld, R. J., & Kirkpatrick, C. F. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01061-7 · Cited by 50
Systemic immune inflammation index with all-cause and cause-specific mortality: a meta-analysis
Li, W., Wang, X., Diao, H., Yang, Y., Ding, L., Huan, W., Chen, Y., & Cui, W. (2024) · Inflammation Research · doi:10.1007/s00011-024-01959-5 · Cited by 51
Lee, Y., Sriram, B., Wang, S., Kogularasu, S., & Chang‐Chien, G. (2024) · Nanomaterials · doi:10.3390/nano14020153 · Cited by 43
“According to recent reports by the World Health Organization (WHO), CVDs are the number one cause of death globally, accounting for an estimated 17.9 million lives each year [1–3].”
BackgroundInfluentialRole of Gut Microbial Metabolites in Cardiovascular Diseases—Current Insights and the Road Ahead
Datta, S., Pasham, S., Sandeep, I. S., Boini, K. M., & Koka, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810208 · Cited by 46
Ridker, P. M., Figtree, G. A., Moorthy, M. V., Mora, S., & Buring, J. E. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf658 · Cited by 42
Wang, L., Wang, Q., Xiong, Y., Shi, W. F., & Xiao, Q. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s540103 · Cited by 46
Galli, M., Abbate, A., Bonaca, M. P., Crea, F., Forte, M., Frati, G., Gaudino, M. F. L., Gibson, C. M., Gorog, D. A., Mehran, R., et al. (2026) · Nature Reviews Cardiology · doi:10.1038/s41569-026-01249-z · Cited by 52
Gallucci, G., Turazza, F. M., Inno, A., Canale, M. L., Silvestris, N., Farì, R., Navazio, A., Pinto, C., & Tarantini, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084232 · Cited by 41
Lee, J., Jeon, S., Lee, J., & Lee, J. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02457-y · Cited by 40
Liu, Q., Cui, H., Si, F., Wu, Y., & Yu, J. (2025) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13702 · Cited by 42
Advantages, applications, and future directions of in vivo aptamer SELEX: A review
Lyu, M., Chan, C. H., Chen, Z., Liu, Y., & Yu, Y. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102575 · Cited by 36
Hormone Replacement Therapy and Cardiovascular Health in Postmenopausal Women
Xia, W., & Khalil, R. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115078 · Cited by 42
Zein, M. A., Khazzeka, A., Khoury, A. E., Zein, J. A., Dima, Z., & Eid, A. H. (2024) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2024.10.009 · Cited by 37
The Role of Adiponectin and ADIPOQ Variation in Metabolic Syndrome: A Narrative Review
Błażejewska, W., Dąbrowska, J., Michałowska, J., & Bogdański, P. (2025) · Genes · doi:10.3390/genes16060699 · Cited by 45
Jones, J. E., Tang, K. S., Barseghian, A., & Wong, N. D. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12237432 · Cited by 36
Advances in exercise-induced vascular adaptation: mechanisms, models, and methods
Sun, H., Zhang, Y., & Shi, L. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1370234 · Cited by 33
Sun, D., Zhang, K., Zheng, F., Yang, G., Yang, M., Xu, Y., Qin, Y., Lin, M., Li, Y., Tan, J., et al. (2024) · Advanced Materials · doi:10.1002/adma.202410802 · Cited by 52
Review on Emerging Therapeutic Strategies for Managing Cardiovascular Disease
Narkhede, M., Pardeshi, A., Bhagat, R., & Dharme, G. (2024) · Current Cardiology Reviews · doi:10.2174/011573403x299265240405080030 · Cited by 40
Coca, A., Sp, W., Camafort, M., López-López, J., & Yang, E. (2024) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2024.04.011 · Cited by 40
Torres‐Martos, Á., Anguita‐Ruiz, A., Bustos‐Aibar, M., Ramírez‐Mena, A., Arteaga, M., Bueno, G., Leis, R., Aguilera, C. M., Alcalá, R., & Alcalá‐Fdez, J. (2024) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2024.102962 · Cited by 32
Breast cancer and cardiovascular health
López‐Fernández, T., Clement, I. M., Aznar, M. C., Barac, A., Bergler-Klein, J. K., Meattini, I., Scott, J. M., Cardinale, D. M., & Dent, S. F. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae637 · Cited by 35
Fiori, E., Fazio, L. D., Pidone, C., Perone, F., Tocci, G., Battistoni, A., Barbato, E., Volpe, M., Gallo, G., & the Young Group of The Italian Society of Cardiovascular Prevention (SIPREC) (2024) · Journal of Hypertension · doi:10.1097/hjh.0000000000003807 · Cited by 39
Targeting lysosomal quality control as a therapeutic strategy against aging and diseases
He, Y., Fan, Y., Ahmadpoor, X., Wang, Y., Li, Z. A., Zhu, W., & Lin, H. (2024) · Medicinal Research Reviews · doi:10.1002/med.22047 · Cited by 30
Mosaic loss of Y chromosome and mortality after coronary angiography
Weyrich, M., Zewinger, S., Sarakpi, T., Rasper, T., Kleber, M. E., Cremer, S., Zanders, L., Fleck, F., Siegbahn, A. G., Wallentin, L. C., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf035 · Cited by 30
Cardiovascular biomarkers for risk stratification in primary prevention
Neumann, F., de Lemos, J. A., Apple, F. S., & Leong, D. P. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf517 · Cited by 32
Saito, Y., Tsujita, K., & Kobayashi, Y. (2024) · Cardiovascular Intervention and Therapeutics · doi:10.1007/s12928-024-01022-4 · Cited by 29
Plaque Vulnerability and Cardiovascular Risk Factor Burden in Acute Coronary Syndrome
Covani, M., Niccoli, G., Fujimoto, D., Scalamera, R., Vergallo, R., Porto, I., McNulty, I. A., Lee, H., Kakuta, T., & Jang, I. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.04.070 · Cited by 32
Bi, F., Gao, C., & Guo, H. (2024) · FASEB BioAdvances · doi:10.1096/fba.2024-00080 · Cited by 32
Shimbo, D., Shah, R. U., Abdalla, M., Agarwal, R., Ahmad, F. S., Anaya, G., Attia, Z. I., Bull, S. S., Chang, A. R., Commodore-Mensah, Y. Y., et al. (2024) · Hypertension · doi:10.1161/hypertensionaha.124.22095 · Cited by 31
Leong, D. P., Yusuf, R., Iqbal, R., Avezum, Á., Yusufali, A., Rosengren, A., Chifamba, J., Lanas, F. T., Díaz, M. L., Miranda, J. J., et al. (2025) · The Lancet Global Health · doi:10.1016/s2214-109x(25)00155-x · Cited by 28
Yadav, R., Mishra, S., Chaturvedi, R., & Pandey, A. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118412 · Cited by 28
Coordinating Efforts to Reduce the Global Incidence of Cardiovascular Disease
Joseph, P. G., & Yusuf, S. (2023) · New England Journal of Medicine · doi:10.1056/nejme2309401 · Cited by 26
Goh, R. S. J., Koh, J., Intaran, M. A. U., Chin, Y. H., Kong, G., Chong, B., Chia, J., Chan, M. Y., Mehta, A., Muthiah, M. D., et al. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.125.041834 · Cited by 32
Carotenoids Intake and Cardiovascular Prevention: A Systematic Review
Cano, S. S., Eguren-García, I., Lasarte-García, Á., Prola, T. A., Diaz, R. M., & Elío, I. (2024) · Nutrients · doi:10.3390/nu16223859 · Cited by 30
“…troponin T, in fl ammatory markers ( C-reactive protein, IL-1, IL-6, IL-18, TNF-α , vascular and cellular adhesion molecules), and high blood pressure (BP), among others, as well as the presence of other conditions such as being overweight, obesity, diabetes, and hypertension [4]. factors [5].”
Hou, Z., Deng, L., Fang, F., Zhao, T., Zhang, Y., Li, G., Miao, M. Z., Zhang, Y., Yu, H., & Liu, X. (2025) · BMC Biology · doi:10.1186/s12915-025-02125-x · Cited by 26
Lv, Q., Chen, S., Luo, D., Liu, H., Song, Y., Liu, M., Xiao, F., Wang, Z., & Wang, L. (2025) · Advanced Materials · doi:10.1002/adma.202413610 · Cited by 31
Lauder, L., Weber, T., Böhm, M., Brouwers, S., Bruno, R. M., Gerdts, E., Kreutz, R. H., Lüscher, T. F., Mancia, G., McEvoy, J. W., et al. (2025) · Nature Reviews Cardiology · doi:10.1038/s41569-025-01187-2 · Cited by 30
Risk Factors for Cardiovascular and Metabolic Disease: Integrating Traditional and Novel Paradigms
Wang, Z., Chen, S., Xu, S., & Weng, J. (2025) · iNew Medicine · doi:10.1002/inm3.70000 · Cited by 32
Damigou, E., Kouvari, M., Chrysohoou, C. A., Barkas, F., Kravvariti, E., Dalmyras, D., Koutsogianni, A. D., Tsioufis, C. P., Pitsavos, C. S., Liberopoulos, E. N., et al. (2023) · Nutrients · doi:10.3390/nu15204428 · Cited by 26
Arrhythmia Detection by Data Fusion of ECG Scalograms and Phasograms
Scarpiniti, M. (2024) · Sensors · doi:10.3390/s24248043 · Cited by 24
A closed-loop bioelectronic patch for intelligent blood pressure management
Zou, Y., Chen, Z., Jin, B., Lyu, L., Xie, Y., Li, Y., Zeng, K., Yan, S., Wu, Z., Chen, W., et al. (2025) · Science Advances · doi:10.1126/sciadv.adx6438 · Cited by 27
Bugiardini, R., Cenko, E., Yoon, J., Bergami, M., Vasiljević, Z., Mendieta, G., Zdravkovic, M. D., Vavlukis, M., Kedev, S. A., Miličić, D., et al. (2024) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2023.100824 · Cited by 27
Present and future of drug therapy in hypertension: an overview
Redón, J., & Carmena, R. (2024) · Blood Pressure · doi:10.1080/08037051.2024.2320401 · Cited by 27
“High blood pressure (HBP) is the leading cause of mortality and years lost to disability (DALYs) [1], and one of the most important risk factors for ischaemic heart disease, heart failure, peripheral arterial disease, stroke, chronic kidney disease [2–6], cognitive impairment and dementia [7–10].”
Cacciatore, S., Calvani, R., Marzetti, E., Coelho‐Júnior, H. J., Picca, A., Fratta, A. E., Esposito, I., Tosato, M., & Landi, F. (2024) · Maturitas · doi:10.1016/j.maturitas.2024.108011 · Cited by 25
Leung, A. A. C., Williams, J. V. A., Padwal, R. S., & McAlister, F. A. (2024) · CJC Open · doi:10.1016/j.cjco.2024.05.012 · Cited by 25
Wang, S., Gao, L., Wang, C., Bai, J., Shen, M., Zhao, X., & Lin, M. F. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1433558 · Cited by 22
Titin-related familial dilated cardiomyopathy: factors associated with disease onset
Johnson, R., Fletcher, R. A., Peters, S. A., Ohanian, M., Soka, M. J., Smolnikov, A., Abihider, K. E., Ackerman, M. J., Ader, F., Akhtar, M. M., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf380 · Cited by 29
Reinikainen, J., Kuulasmaa, K., Oskarsson, V., Amouyel, P., Biasch, K., Brenner, H., Ponti, R. D., Donfrancesco, C., Drygas, W., Ferrières, J., et al. (2023) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwad359 · Cited by 24
Zheng, Z., Liang, Y., Lyu, R., Junjie, B., Huang, Y., Zhou, A., Ma, H., Wang, J., Meng, X., Shao, C., et al. (2024) · ACM Conference on Embedded Networked Sensor Systems (SenSys) · doi:10.1145/3666025.3699370 · Cited by 25
Jia, X., Hu, C., Xu, Y., Yin, Y., Lin, H., Zheng, R., Li, M., Xu, M., Wang, T., Zhao, Z., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102309 · Cited by 28
Baretella, O., Blum, M. R., Abolhassani, N., Alwan, H., Wildisen, L., Giovane, C. D., Tal, K., Moutzouri, E., Åsvold, B. O., Cappola, A. R., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae860 · Cited by 21
Młynarska, E., Bojdo, K., Frankenstein, H., Kustosik, N., Mstowska, W., Przybylak, A., Rysz, J., & Franczyk, B. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14030887 · Cited by 26
Lin, L., Chen, L., Chen, G.-Q., Lu, C., & Hong, F. F. (2024) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2024.122063 · Cited by 21
Epidemiology of cardiovascular risk factors: Non-behavioural risk factors
Olié, V., Gabet, A., Grave, C., Helft, G., Fosse‐Edorh, S., Piffaretti, C., Lailler, G., Verdot, C., Deschamps, V., Vay‐Demouy, J., et al. (2024) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2024.08.005 · Cited by 20
Pourmontaseri, H., Bazmi, S., Sepehrinia, M., Mostafavi, A., Arefnezhad, R., Homayounfar, R., & Vahid, F. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1497364 · Cited by 21
Wang, A., Adeli, A., Kylhammar, D., Swahn, E., Engvall, J. E., Lind, L., Söderberg, S., Blomberg, A., Engström, G., Spaak, J., et al. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf157 · Cited by 21
Polygenic risk and incident coronary heart disease in a large multiethnic cohort
Iribarren, C., Lü, M., Elosúa, R., Gulati, M., Wong, N. D., Blumenthal, R. S., Nissen, S. E., & Rana, J. S. (2024) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2024.100661 · Cited by 19
Liu, Y. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1486697 · Cited by 18
Management of Postpartum Preeclampsia and Hypertensive Disorders (MOPP)
Rosenfeld, E. B., Sagaram, D., Lee, R., Sadural, E., Miller, R. C., Lin, R., Jenkins, D., Blackledge, K. T., Nikodijevic, I., Rizzo, A., et al. (2025) · JACC Advances · doi:10.1016/j.jacadv.2025.101617 · Cited by 18
Li, Z., Zhang, S., Xiao, Q., Shui, S., Dong, P., Jiang, Y., Chen, Y., Lan, F., Peng, Y., Ying, B., et al. (2025) · ACS Nano · doi:10.1021/acsnano.4c14656 · Cited by 20
Advancing biocompatible metal-organic frameworks in personalized biomedical applications
Yu, Z., Chivu, A., Dai, J., Patra, H. K., Zou, J., & Hu, Z. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.217262 · Cited by 21
Racial and Ethnic Disparities in Primary Prevention of Cardiovascular Disease
Ali, M., Nacer, H., Lawson, C. A., & Khunti, K. (2024) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2024.01.028 · Cited by 26
Tian, J., Shen, Z., Sutherland, B. A., Cicuttini, F., Jones, G., & Pan, F. (2024) · British Journal of Anaesthesia · doi:10.1016/j.bja.2024.06.021 · Cited by 18
The role and underlying mechanisms of irisin in exercise-mediated cardiovascular protection
Guo, W., Peng, J., Su, J., Xia, J., Deng, W., Li, P., Chen, Y., Liu, G., Wang, S., & Huang, J. (2024) · PeerJ · doi:10.7717/peerj.18413 · Cited by 21
Intelligent ring for dynamic pulse wave monitoring using fine tubular triboelectric nanogenerators
Wu, Y., Li, Y., Wang, X., Guo, P., Luo, H., Li, X., Zhu, X., & Yang, J. (2024) · Nano Energy · doi:10.1016/j.nanoen.2024.110581 · Cited by 18
NETosis in myocardial ischemia‑reperfusion injury: From mechanisms to therapies (Review)
Zhang, Z., Wang, Y., Li, T., & Wang, H. (2025) · Biomedical Reports · doi:10.3892/br.2025.1991 · Cited by 19
The Importance of Cultural Awareness in the Management of Heart Failure: A Narrative Review
Beattie, J. M., Castiello, T., & Jaarsma, T. (2024) · Vascular Health and Risk Management · doi:10.2147/vhrm.s392636 · Cited by 20
Damigou, E., Georgoulis, M., Chrysohoou, C. A., Barkas, F., Vlachopoulou, E., Adamidis, P. S., Kravvariti, E., Tsioufis, C. P., Pitsavos, C. E., Liberopoulos, E. N., et al. (2024) · Nutrients · doi:10.3390/nu16081128 · Cited by 20
Okamoto, N., Atsumi, T., Takagi, M., Takahashi, N., Takeuchi, T., Tamura, N., Nakajima, A., Nakajima, A., Fujii, T., Matsuno, H., et al. (2024) · Modern Rheumatology · doi:10.1093/mr/roae064 · Cited by 17
Metadata
- Authors
- The Global Cardiovascular Risk Consortium
- Affiliations
- University Medical Center Hamburg-Eppendorf (DE)
- Corresponding author
- The Global Cardiovascular Risk Consortium
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2023-10-05
- Volume
- 389
- Issue
- 14
- Pages
- 1273-1285
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC10589462
- OpenAlex
- W4386194106
- Cited by
- 909
- References
- 35
- Citations by year
- 2026: 285 · 2025: 359 · 2024: 242 · 2023: 23
- FWCI
- 47.54
- Type
- journal article
- Language
- en
- Open access
- Licence
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by-nc-nd)
- Research Portal (Queen's University Belfast) (publishedVersion, cc-by)
- PubMed Central (acceptedVersion, cc-by)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Lithuanian University of Health Sciences (submittedVersion, cc-by)
- Digital Commons-TMC (Texas Medical Center) (submittedVersion)
- HAL (submittedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion, other-oa)
- BOA (University of Milano-Bicocca) (submittedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- IrInSubria (University of Insubria) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- NORA - Norwegian Open Research Archives (submittedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- Duo Research Archive (University of Oslo) (submittedVersion)
- STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
- Funders
- European Union AFFECT-EU (Horizon 2020, No. 847770)
- German Center for Cardiovascular Research (not applicable)
- European Union MORGAM (Biomed, BMH4-CT98-3183)
- European Union GenomEUtwin (FP5, QLG2-CT-2002-01254)
- European Union ENGAGE (FP7, HEALTH-F4-2007-201413)
- European Union CHANCES (FP7, HEALTH-F3-2010-242244)
- European Union BiomarCaRE (FP7, HEALTH-F2-2011-278913)
- European Union euCanSHare (Horizon 2020, No. 825903)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- modifiable risk factors, cardiovascular disease, all-cause mortality, population attributable fraction, body mass index, systolic blood pressure, non-HDL cholesterol, smoking, diabetes mellitus, sex differences, regional variation, global cardiovascular risk, cohort studies, cardiovascular disease incidence, women's health
- MeSH terms
- Heart Disease Risk Factors, Cardiovascular Diseases, Diabetes Mellitus, Female, Humans, Male, Middle Aged, Risk Factors, Smoking, Internationality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.